SUGARAY D 50/5MG (Dapagliflozin (5mg) + Sitagliptin (50mg))

Sugaray D 5mg/50mg Tablet is a therapeutic combination designed to aid in managing glucose levels in individuals diagnosed with type 2 diabetes mellitus. This medication is intended to be utilized alongside a balanced diet and regular physical activity to enhance overall blood sugar regulation in adult patients. The formulation works by supporting the effective use of insulin within the body, which contributes to a decrease in blood glucose concentration. It is important for users to take the tablet consistently, either with meals or on an empty stomach, at a time that suits their routine, while maintaining the same schedule each day. Dosing will be determined by a healthcare provider, and it is crucial not to discontinue use of the medication without medical guidance, as this may lead to an escalation in blood sugar levels, which can result in significant health complications such as renal impairment and vision loss. The tablet is part of a comprehensive diabetes management strategy, emphasizing the importance of dietary changes, consistent exercise, and weight management as prescribed by a healthcare professional. Hydration is also encouraged during treatment to help prevent the risk of dehydration, as some users may experience urinary and respiratory complications, including infections. Adherence to hygiene practices is advisable to mitigate the risk of developing infections, particularly in sensitive areas.